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Abstract 
Septic shock remains a major cause of mor-
bidity and mortality among children, mainly
due to acute hemodynamic compromise and
multiple organ failures. In the last decade,
international guidelines for the management
of septic shock, as well as clinical practice
parameters for hemodynamic support of pedi-
atric patients, have been published. Early
recognition and aggressive therapy of septic
shock, by means of abundant fluid resuscita-
tion, use of catecholamines and other adjuvant
drugs, are widely considered of pivotal impor-
tance to improve the short and long-term out-
come of these patients. The aim of this paper
is to summarize the modern approach to septic
shock in children, particularly in its very initial
phase, when pediatric healthcare providers
may be required to intervene in the pre-inten-
sive care unit setting or just on admission in
the pediatric intensive care unit.
Introduction
Severe sepsis and septic shock constitute a
relevant cause of morbidity and mortality in
critically ill children.1-3 Actually, most deaths
from sepsis occur globally in locations without
intensive care units, and many of them could
be prevented using relatively simple measures
as recommended by the World Health
Organization-Integrated Management of
Childhood Illnesses guidelines.4 On this
regard, The World Federation of Pediatric
Intensive Care and Critical Care Societies
(WFPICCS) has recently launched an impor-
tant quality improvement program (The Global
Pediatric Sepsis Initiative at http://www.
wfpiccs.org/sepsis and http://www. pediatric-
sepsis.org), with the goal of ameliorating the
outcome of septic children worldwide, regard-
less the amount of available resources.5
Nonetheless, septic shock still represent a
clinical challenge even in developed countries,
being a leading causes of admissions to the
paediatric emergency department and the
pediatric intensive care unit.
In the last decades, several consensus con-
ferences about the criteria for defining sepsis
and related conditions have been held.6
However, definitions of sepsis, severe sepsis,
septic shock and multiple organ
dysfunction/failure syndromes in children are
slightly different when compared to those used
for adults. In particular, septic shock in chil-
dren is defined as presence of sepsis plus
signs of cardiovascular organ dysfunction,  not
necessarily including hypotension, whilst in
adult septic shock hypotension must be pres-
ent. (Table 1)6,7 In addition, signs of organ dys-
function depend on age-specific heart rate,
respiratory rate, and white blood cell count cut-
offs, which characteristically change in differ-
ent paediatric age groups. 
Guidelines for the management of severe
sepsis and septic shock, sponsored by the
International Surviving Sepsis Campaign, and
clinical practice parameters released by the
American College of Critical Care Medicine
(ACCM) for hemodynamic support of paedi-
atric and neonatal septic shock have been pub-
lished and recently updated.8-11
The aim of this paper is to summarize the
modern approach to septic shock in children in
its very initial phase, emphasising the pivotal
role of early recognition and prompt manage-
ment of this life-threatening condition, in
PICU  but also in the pre-ICU setting. 
Pathophysiology of septicshock
Shock is a complex clinical syndrome
caused by an acute failure of circulatory func-
tion, with inadequate tissue and organ perfu-
sion, where delivery of oxygen and substrates
to body tissues, as well as removal of metabol-
ic waste products are inadequate. This results
in cellular dysfunction, which may eventually
lead to cell death. Shock is the common end-
point of many pathophysiological pathways.
There are three major categories of shock:
hypovolemic, cardiogenic and distributive,
with a degree of overlap between these. Septic
shock usually fall into the categories of distrib-
utive and hypovolemic shock. In the distribu-
tive shock is prevalent a circulatory maldistrib-
ution associated with peripheral vasodilata-
tion, arterial and capillary shunting, whereas
in the hypovolemic shock there is inadequate
circulating blood volume, despite peripheral
vasoconstriction.
Hypotension frequently constitutes one of
the prominent features of shock, but could be a
late sign in pediatric patients.7,10,11
The most common causes of septic shock
are of bacterial origin, a classic example being
meningococcal disease. However, any organ-
ism can precipitate severe sepsis and septic
shock, including bacteria, viruses, mycobacte-
ria and fungi, especially in the immunocom-
promised host.
Early recognition of paediatricseptic shock
In the management of septic shock, early
diagnosis and prompt treatment have the
greatest impact on clinical course and patient
outcome. Indeed, early recognition of septic
shock and institution of antibiotic therapy can
reduce mortality in children.12,13 Furthermore,
early institution of resuscitative measures,
particularly by using aggressive fluid replace-
ment strategies, may prevent the child from
entering uncompensated or irreversible shock,
thereby reducing morbidity and mortality.
However, diagnosis of sepsis can be particu-
larly difficult in children, in whom a specific
signs of sepsis, e.g. tachycardia, tachypnoea
and fever, need a special interpretation due to
the variable range of normality depending on
the patient age. Furthermore, previously
healthy children with intact cardiovascular
homeostatic mechanisms can compensate
extremely well during hypoperfusion states for
relatively long periods. Thus, shock in children
should be suspected by clinical and laboratory
signs, including altered mental status, tachyp-
noea and tachycardia, hypothermia or hyper-
thermia, changes in peripheral perfusion,
together with reduction of urine output, meta-
bolic acidosis and increased blood lactate.
Importantly, hypotension is not necessary for
the clinical diagnosis of septic shock, even
though its presence in any child with clinical
suspicion of infection is confirmatory.7,11
In the emergency department setting, chil-
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dren with severe infections and changes in
peripheral perfusion are frequently described
as in warm shock or cold shock status, on the
basis of first clinical examination (Table 2).14
Early in the course of the disease process,
common observations usually include abnor-
mal temperature regulation, flushed warm
skin, a widened pulse pressure (warm shock),
tachycardia, tachypnoea, whereas mean arteri-
al pressure is frequently maintained. Clinical
signs of late septic shock include hypotension,
tachycardia with narrow pulse pressure, cold
extremities (cold shock), rapid shallow breath-
ing, oliguria, altered level of consciousness,
and cyanosis due to pulmonary ventilation per-
fusion mismatch or underlying pulmonary dis-
eases. At present, international consensus rec-
ommends early recognition of pediatric septic
shock using simply clinical examination, not
biochemical tests, event though some experts
suggest to consider lactate levels as well.11
Early management of paedi-atric septic shock: the goldenhour
Shock can rapidly evolve through different
phases, usually from a compensated to an
uncompensated status, which may ultimately
become irreversible. Aggressive treatment
should be initiated in all cases where shock is
suspected. In fact, the mortality and outcome
of septic shock is likely influenced by the speed
and appropriateness of therapy administered
in the initial hours after the syndrome devel-
ops.12,15,16 The goal is to reverse shock and pre-
vent multiple organ dysfunction. To achieve
this, the initial management of septic shock
(first hour) should focus on some major thera-
peutic end points of resuscitation, which
include normalization of heart rate and blood
pressure (adjusted for age), capillary refill of
less than 2 seconds, normal pulses with no dif-
ferential between peripheral and central puls-
es, warm extremities, normal mental status,
urine output greater than 1 mL/kg/hr. In addi-
tion, normal glucose and ionized calcium con-
centrations should be achieved and main-
tained.11
Once shock is suspected, appropriate sup-
portive measures must be instituted as soon as
possible, ideally following the ACCM guide-
lines.11 These include securing airway patency,
providing supplemental oxygen and positive-
pressure ventilation, achieving vascular
access, infusing as many fluids as needed,
starting empiric antibiotic therapy, and provid-
ing support with inotropes and vasopressors,
as clinically indicated. Importantly, empiric
antibiotic treatment should not be delayed
while waiting blood cultures to be sampled. 
Two levels of care can be then summarized:
first, early fluid load, mostly for outpatients
with community acquired infections; second,
advanced technology for children with
fluid/dopamine refractory illness, scarcely
responding to the initial stabilization
attempts. These interventions can be located
at the onset and at the end of the golden hour,
according to international guidelines, where
time intervals for intensivists have been clear-
ly indicated.11 Indeed, the early interpretation
of hemodynamic pattern of septic shock can
guide further therapeutic interventions and
vasoactive agents introduction. Thus, early
referral to highly specialised centres, capable
to provide more sophisticated monitoring and
treatment, is strongly recommended. ABCs: airway and breathing
Airway, breathing and circulation remain
the fundamental principles of resuscitation
also in patients with septic shock. Priority is
given to the airway, which is immediately
assessed and secured, if necessary. High flow
oxygen via facemask or nasal canulae should
be given, even in the absence of respiratory
distress or hypoxemia. 
Aggressive airway management and  venti-
lation should be considered in any patient not
responding to fluid resuscitation and peripher-
ally administered inotropes. Indeed, early intu-
bation and mechanical ventilation may support
cardiac output (CO) by reducing the work of
breathing, reduce oxygen consumption by
sedation, facilitate procedures for establishing
invasive hemodynamic monitoring, provide
airway protection.11Vascular access
Rapid attainment of a vascular access is of
critical importance, possibly through the place-
ment of two large bore peripheral venous
catheters. If these catheters cannot be
obtained easily, the intraosseous route or a
central venous catheter should be considered,
depending upon the available expertise. 
If at all possible, blood samples should be
taken for haematological parameters, urea and
electrolytes, blood glucose, culture and cross-
match. At this point empirical antibiotic thera-
py should be started intravenously. 
Fluid resuscitation
Rapid fluid boluses of 20 mL/kg should be
administered (possibly over five minutes),
observing for the development of lung rales or
hepatomegaly. Up to 60 mL/kg may be neces-
sary in the first hour; however, in some
patients aliquots exceeding 150-200 ml/kg may
be required in the first hour. Fluid should be
pushed manually or by a pressure bag, with a
goal of attaining normal perfusion and blood
pressure.11 Use of both crystalloid or colloid
solutions is generally considered appropriate.
In special cases, e.g.  when the source of hypo-
volemia is hemorrhage, transfusion with
packed red blood cells could be also considered,
particularly with haemoglobin  values below 10
ng/dL. 
However, there is little evidence about the
best type of resuscitation fluid, the appropriate
timing, volume, and rate of fluid administra-
tion.17 In particular, no clear advantages have
been demonstrated by using cristalloids rather
than colloids in septic shock patients.18
Interestingly, recent findings challenge the
importance of bolus resuscitation as a lifesav-
ing intervention in resource-limited settings
for children with shock who do not have
hypotension, raising questions regarding
fluid-resuscitation guidelines in other settings
as well.19 Further research is clearly needed to
clarify such a controversial issue. Inotropic support
Children with septic shock uniformly
require some vasoactive support during and
after fluid resuscitation. Importantly, in
patients not responsive to fluid resuscitation,
inotropic support should be started via a sec-
Review
Table 1. Cardiovascular dysfunction criteria (modified from Goldstein et al.7).
Despite administration of isotonic intravenous fluid bolus > 40 mL/kg in 1 hr: 
Decrease in blood pressure Need for vasoactive drug Two of the following:
(hypotension) < 5th percentile to maintain blood pressure 1) unexplained metabolic 
for age or systolic BP < 2 SD in normal range (dopamine acidosis: base deficit > 5.0 mEq/L
below normal for age >5 mcg/kg/min or dobutamine, 2) Increased arterial lactate > 2
adrenaline, or noradrenaline times upper limit of normal
at any dose) 3) Oliguria: urine output <0.5 mL/kg/hr
4) Prolonged capillary refill: > 5 secs
5) Core to peripheral temperature gap >3°C
Table 2. Clinical characteristics of cold and
warm shock (modified from Saladino et al. 14).
Cold shock Warm shock
Capillary > 2 seconds Flash capillary refill
refill 
Peripheral Diminished Bounding
pulses
Mottling Present Absent
of skin
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ond peripheral access, until a safer central
venous access is obtained. 
Dopamine can be used and titrated as the
first-line agent, up to 10 mcg/kg/min. However,
if the patient is not rapidly responsive to ther-
apy, then adrenaline or noradrenaline should
be infused to restore normal blood pressure
and perfusion.9,11 In general, adrenaline rang-
ing from 0.05 to 0.3 mcg/kg/min should be used
in patients with normal or low blood pressure
and cold shock, whilst noradrenaline should be
titrated in patients with low blood pressure and
warm shock. Corticosteroids
Some patients with septic shock may suffer
of severe adrenal insufficiency, which could
partially explain a scarce response to fluid and
catecholamine therapy. Risk factors for such
condition include purpura fulminans, prior
corticosteroid use and pituitary or adrenal
abnormalities. In patients with fluid refractory,
catecholamine resistant shock, intermittent or
continuous infusions of hydrocortisone, rang-
ing from 1 up to 50 mg/kg/day is recommended
within 60 min of diagnosis of shock.9,11Other therapies for acute manage-ment of septic shock
Beyond the first hour of treatment, several
adjuvant therapies, including vasopressin, ter-
lipressin, levosimendan, milrinone, immuno -
globulins, and protein C concentrate, have
been attempted in pediatric septic shock, even
though evidence to support their use are still
lacking.9,11,20-24
Finally, children with septic shock scarcely
responding to initial aggressive treatments
must be suspected to have unrecognized mor-
bidities, including pericardial effusion, pneu-
mothorax, ongoing blood loss, hypoadrenalism,
hypothyroidism, inborn errors of metabolism,
or congenital heart disease. When these caus-
es have been excluded, extreme therapeutic
options such as extracorporeal membrane oxy-
genation (ECMO) should be considered.9-11Advanced non invasive hemodynamicmonitoring
The invasive monitoring of cardiac output is
not common practice in the pediatric emer-
gency department. Interestingly, newer, nonin-
vasive, ultrasound techniques offer the oppor-
tunity to monitor the hemodynamic patterns of
children with septic shock, at a much earlier
stage than that usually accomplished in the
intensive care unit.
In a recent study, the hemodynamic patterns
of children with suspected fluid-resistant sep-
tic shock was investigated by means of a non-
invasive cardiac output device. Patients who
presented with central venous catheter-related
sepsis predominantly demonstrated a pattern
of elevated cardiac index with low systemic
vascular resistance (warm shock), whereas
those who presented with community acquired
sepsis predominantly exhibited a low or nor-
mal cardiac index, with normal or high sys-
temic vascular resistance (cold shock).25
Theoretically, such devices may provide a
more specific assessment of the hemodynamic
status of these patients, even in the emer-
gency department or during transportation,
helping the clinician to individualize the ther-
apeutic management.Transfer of patients with septicshock to a referral centre
Even when initial stabilisation has been cor-
rectly achieved, the early referral to a high-
level PICU may be life-saving for a child with
evolving septic shock. Indeed, more advanced
monitoring and treatment are best offered in
an experienced PICU setting. Areas lacking
specialised paediatric ICUs should arrange for
a transfer system towards a tertiary PICU, ide-
ally by means of a specialised transport team.
Conclusions
Septic shock in children still constitutes a
clinical challenge for healthcare providers,
both in the emergency department and the
intensive care unit. Early diagnosis, allowing
rapid therapeutic intervention, is essential in
improving the outcome of these patients.
Guidelines for the management of septic shock
have been published and are regularly updated
by highly recognized international bodies.
Current treatment includes early fluid resusci-
tation, tailored use of inotropes and vasopres-
sors, and use of adjuvant treatments, such as
hydrocortisone. Novel promising therapies are
on the horizon, but hitherto they remain large-
ly unproven in terms of efficacy and safety. 
Even though remarkable advances have
been made in the management of paediatric
septic shock, further research is still needed in
order to improve the short and long-term out-
come of these high-risk patients. 
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